| Benign Prostatic Hyperplasia (BPH) | |
|
We currently are not conducting clinical trials for this category in which we are seeking participants. Please check back as this is frequently updated. List of Completed Trials for Benign Prostatic Hyperplasia (BPH) Protocol Number: H6D-MC-LVHK 07/2006 – 02/2008 Sponsor: Lilly, ICOS, LLC Title: A randomized, double-blind, placebo controlled, parallel design, multi-center study to evaluate the urodynamic effects of Tadalafil once a day for 12 weeks in men with signs and symptoms of Benign Prostatic Hyperplasia. Clinical Research Coordinators: Patricia Edwards, RN (336) 274-1114 ext. 5322 Karen Michael, RN (336) 274-1114 ext. 5328 E-mail address: research@allianceurology.com |
|
All trademarks and registered trademarks are of their respective companies.
Site powered by Medfusion, Inc.
Website Graphics by Vintage Marketing